NIFTY 50▲24,936.40
84.25 (0.34%)
SENSEX▲81,559.54
375.61 (0.46%)
NIFTY BANK▲51,117.80
540.95 (1.07%)
TATA MOTORS▼1,038.70
-10.65 (-1.01%)
SUZLON ENERGY▼74.34
-0.38 (-0.51%)
INDIAN RAILWAY FINANCE CORP▼168.33
-1.52 (-0.89%)
TATA STEEL▼149.47
-1.75 (-1.16%)
TATA POWER▲417.85
0.85 (0.20%)
RAIL VIKAS NIGAM▼562.90
-6.65 (-1.17%)
INDIAN RENEWABLE ENERGY▼223.17
-4.23 (-1.86%)
RELIANCE INDUSTRIES▼2,924.90
-4.75 (-0.16%)
VODAFONE IDEA▼13.20
-0.15 (-1.12%)
ADANI POWER▲635.20
0.50 (0.08%)
ZOMATO▲263.20
3.25 (1.25%)
YES BANK▼22.89
-0.25 (-1.08%)
NHPC▼94.87
-1.22 (-1.27%)
RELIANCE POWER▼29.72
-0.50 (-1.65%)
STATE BANK OF INDIA▲784.25
1.75 (0.22%)
HDFC BANK▲1,646.50
9.55 (0.58%)
JIO FIN SERVICES LTD▲341.70
4.85 (1.44%)
ADANI PORT & SEZ▼1,435.90
-6.50 (-0.45%)
BHARAT ELECTRONICS▼281.55
-2.05 (-0.72%)
GTL INFRA▼2.38
-0.07 (-2.86%)
INDIAN OIL CORP▼175.34
-1.30 (-0.74%)
MRF▼1,33,979.30
-281.45 (-0.21%)
INDIAN RAILWAY TOURISM CORP▼927.00
-9.50 (-1.01%)
RATTANINDIA POWER▼15.13
-0.24 (-1.56%)
OLA ELECTRIC MOBILITY LTD▲114.58
5.01 (4.57%)
GlaxoSmithKline Pharma Share Price
GLAXO
₹2,849.95+₹18.35 (0.65%) TodayLast updated on 09 Sep, 2024 | 15:29 IST
Please wait...
What’s in news?
Company overview
Financial performance
Market cap
| Open₹2,832.65 | Close₹2,831.60 |
Circuit range₹3,397.90 - ₹2,265.30 | Day range₹2,771.05 - ₹2,870.00 | Year range₹1,385.05 - ₹3,088.00 |
Volume54,372 | Avg. traded₹2,828.51 | Revenue (12m)₹3,507 Crs |
GlaxoSmithKline PharmaGlaxoSmithKline Pharmaceuticals Limited is an India-based global healthcare company. The Company is engaged in the business of manufacturing, distributing and trading in pharmaceuticals. It has three product areas: vaccines, specialty and general medicines. Its general medicines business has a portfolio of medicines in anti-infectives, pain, dermatology and vitamins. Its general medicines brands include Augmentin, Calpol, Ceftum, Eltroxin, CCM, Neosporin, Betnovate, T-bact and Physiogel. Its T-bact brand products are used in specific types of bacterial skin infections. The Company's vaccine brands include Shingrix, Infanrix Hexa, Synflorix, Boostrix, Havrix, Menveo, Fluarix Tetra and Varilrix. Its specialty medicines business is focused on developing medicines for respiratory diseases and human immunodeficiency virus. The Company is also building its presence in other therapeutic areas, such as immunology and oncology. Its specialty medicines brands include Nucala and Trelegy Ellipta.
GlaxoSmithKline Pharma Key indicators
52 week high₹3,088.00 | 52 week low₹1,385.05 | P/E ratio74.96 |
P/B ratio24.36 | ROE32.96% | ROCE45.85% |
Dividend yield1.13% | Debt/Equity ratio | EPS34.51 |
Learn more
Featured in
Investment checklist: (3/6)
Equity returns
Dividend returns
Safety factor
Growth factor
Debt vs Equity
Profit factor
The investment checklist helps you understand a company's financial health at a glance and identify quality investment opportunities easily
Analyst ratings:
Analyst ratings:
50%
Hold
50%
Sell
0%
This analysis is based on the reviews of 4 experts in the last 7 days
Fundamentals
Financial ratios
Operating profit margin27.4% | Net profit margin15.64% |
ROE32.96% | ROA17.73% |
ROCE45.85% |
Learn more
GlaxoSmithKline Pharma Share Price history
Day | Open | Close | Day’s change |
---|---|---|---|
Fri, Sep 6 2024 | ₹2,815.00 | ₹2,831.60 | |
Thu, Sep 5 2024 | ₹2,848.95 | ₹2,813.95 | -1.23% |
Wed, Sep 4 2024 | ₹2,833.05 | ₹2,848.95 | |
Tue, Sep 3 2024 | ₹2,792.90 | ₹2,832.15 | |
Mon, Sep 2 2024 | ₹2,751.85 | ₹2,781.65 | |
Fri, Aug 30 2024 | ₹2,786.00 | ₹2,745.10 | -0.78% |
Thu, Aug 29 2024 | ₹2,815.00 | ₹2,766.70 | -1.38% |
Wed, Aug 28 2024 | ₹2,893.70 | ₹2,805.50 | -2.39% |
Events
Corporate actions
Dividend • ₹32/share
Ex date 31 May 2024
Dividend • ₹32/share
Ex date 30 Jun 2023
Dividend • ₹60/share
Ex date 07 Jul 2022
Dividend • ₹30/share
Ex date 07 Jul 2022
Learn more